RadEditor - HTML WYSIWYG Editor. MS Word-like content editing experience thanks to a rich set of formatting tools, dropdowns, dialogs, system modules and built-in spell-check.
RadEditor's components - toolbar, content area, modes and modules
   
Toolbar's wrapper  
Content area wrapper
RadEditor's bottom area: Design, Html and Preview modes, Statistics module and resize handle.
It contains RadEditor's Modes/views (HTML, Design and Preview), Statistics and Resizer
Editor Mode buttonsStatistics moduleEditor resizer
Words: 0   Characters: 0 
 
RadEditor's Modules - special tools used to provide extra information such as Tag Inspector, Real Time HTML Viewer, Tag Properties and other.
   
 

Table 1

Pediatric Cancer Incidence in Idaho, 1982-1996

International Classification of Childhood Grouping Incidence Counts, 15 Year Total Percent of Total Cases Crude Rates
15 Year Average
Age-Adjusted Rates
1982-1996
US Age-Adjusted Rates
1990-1994
Expected Cases
Idaho
P-value
  Age 0-4 Age 5-9 Age 10-14 Age 0-14   Age 0-4 Age 5-9 Age 10-14   All Races Whites    
All Cancers 268 150 184 602 100% 202.6 110.7 136.5 147.2 139.7 142.9 586.7 0.538
Leukemias 91 44 54 189 31% 68.8 32.5 40.1 46.0 43.1 45.2 187.7 0.942
Lymphocytic leukemia
76 34 37 147 24% 57.4 25.1 27.5 35.5 34.0 36.4 151.7 0.743
Acute non-lymphocytic leukemia
11 6 11 28 5% 8.3 4.4 8.2 6.9 6.6 6.5 26.5 0.819
Lymphomas & Other Reticuloendothelial Neoplasms 12 24 33 69 11% 9.1 17.7 24.5 17.6 15.3 15.7 61.5 0.369
Hodgkin's Disease
2 8 13 23 4% 1.5 5.9 9.6 5.9 6.2 6.5 24.7 0.839
Non-Hodgkin's Lymphoma
3 10 11 24 4% 2.3 7.4 8.2 6.1 5.8 5.8 23.0 0.888
CNS & Misc. Intracranial & Intraspinal Neoplasms 50 45 25 120 20% 37.8 33.2 18.6 29.3 30.3 31.0 126.1 0.624
Astrocytoma
29 25 12 66 11% 21.9 18.4 8.9 16.1 14.6 15.2 61.1 0.560
Medulloblastoma
5 9 7 21 3% 3.8 6.6 5.2 5.3 7.3 7.7 31.6 0.060
Sympthetic Nervous System Tumors 36 1 1 38 6% 27.2 0.7 0.7 8.6 9.4 9.8 43.1 0.489
Neuroblastoma & ganglioneuroblastoma
36 0 1 37 6% 27.2 - 0.7 8.3 9.0 9.5 41.8 0.517
Retinoblatomas 10 0 0 10 2% 7.6 - - 2.2 3.8 3.6 15.6 0.182
Renal Tumors 33 9 0 42 7% 24.9 6.6 - 9.7 7.7 7.8 33.3 0.162
Wilms' Tumors
31 9 0 40 7% 23.4 6.6 - 9.2 7.4 7.6 32.5 0.224
Hepatic Tumors 2 1 1 3 0% 1.5 0.7 - 0.7 1.9 2.0 8.6 0.055
Malignant Bone Tumors 2 7 25 34 6% 1.5 5.2 18.6 8.9 6.9 7.3 28.0 0.302
Osteosarcoma
2 2 15 19 3% 1.5 1.5 11.1 5.0 3.9 3.9 15.0 0.357
Ewing's Sarcoma
0 5 7 12 2% - 3.7 5.2 3.1 2.4 2.8 10.6 0.757
Soft Tissue Sarcoma 19 8 20 47 8% 14.4 5.9 14.8 11.6 9.4 9.2 37.1 0.132
Rhabdomyosarcoma & embryonal sarcoma
12 5 11 28 5% 9.1 3.7 8.2 6.9 4.7 4.8 19.8 0.095
Germ Cell, Trophoblastic & Other Gonadal Neoplasms 12 3 11 26 4% 9.1 2.2 8.2 6.4 5.3 4.9 19.9 0.220
Other Epithelial & Unspecified Neoplasms 1 8 15 24 4% 0.8 5.9 11.1 6.3 6.7 6.5 25.6 0.846

Study
Table 1
Table 2
Table 3
Table 4
Table 5
Appendix